Clene Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Clene Inc
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
/ 
Frequently asked questions
To buy Clene Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Clene Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Clene Inc is CLNN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Clene Inc has its primary listing on NASDAQ. You can trade Clene Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Clene Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Clene Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Clene Inc.